Knight Therapeutics lifts 2026 revenue guide to C$560-570 million as Q3 sales rise 13%
GlobeNewswire · · AI-summarised by FinFlash
Montreal-based Knight Therapeutics reported third-quarter revenue of C Higher guidance and net cash of C Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context